QQQ   353.97 (-1.57%)
AAPL   172.08 (-2.27%)
MSFT   310.65 (-2.17%)
META   298.04 (-0.93%)
GOOGL   128.15 (-2.26%)
AMZN   125.97 (-4.04%)
TSLA   244.23 (-1.12%)
NVDA   420.21 (-0.48%)
NIO   8.42 (+0.84%)
BABA   85.80 (-1.63%)
AMD   95.67 (-1.76%)
T   15.01 (-0.33%)
F   12.42 (-1.27%)
MU   67.82 (-1.11%)
CGC   0.90 (-4.31%)
GE   109.86 (-1.66%)
DIS   79.85 (-1.43%)
AMC   7.93 (-2.58%)
PFE   32.51 (-1.43%)
PYPL   58.75 (-0.19%)
NFLX   377.97 (-1.77%)
QQQ   353.97 (-1.57%)
AAPL   172.08 (-2.27%)
MSFT   310.65 (-2.17%)
META   298.04 (-0.93%)
GOOGL   128.15 (-2.26%)
AMZN   125.97 (-4.04%)
TSLA   244.23 (-1.12%)
NVDA   420.21 (-0.48%)
NIO   8.42 (+0.84%)
BABA   85.80 (-1.63%)
AMD   95.67 (-1.76%)
T   15.01 (-0.33%)
F   12.42 (-1.27%)
MU   67.82 (-1.11%)
CGC   0.90 (-4.31%)
GE   109.86 (-1.66%)
DIS   79.85 (-1.43%)
AMC   7.93 (-2.58%)
PFE   32.51 (-1.43%)
PYPL   58.75 (-0.19%)
NFLX   377.97 (-1.77%)
QQQ   353.97 (-1.57%)
AAPL   172.08 (-2.27%)
MSFT   310.65 (-2.17%)
META   298.04 (-0.93%)
GOOGL   128.15 (-2.26%)
AMZN   125.97 (-4.04%)
TSLA   244.23 (-1.12%)
NVDA   420.21 (-0.48%)
NIO   8.42 (+0.84%)
BABA   85.80 (-1.63%)
AMD   95.67 (-1.76%)
T   15.01 (-0.33%)
F   12.42 (-1.27%)
MU   67.82 (-1.11%)
CGC   0.90 (-4.31%)
GE   109.86 (-1.66%)
DIS   79.85 (-1.43%)
AMC   7.93 (-2.58%)
PFE   32.51 (-1.43%)
PYPL   58.75 (-0.19%)
NFLX   377.97 (-1.77%)
QQQ   353.97 (-1.57%)
AAPL   172.08 (-2.27%)
MSFT   310.65 (-2.17%)
META   298.04 (-0.93%)
GOOGL   128.15 (-2.26%)
AMZN   125.97 (-4.04%)
TSLA   244.23 (-1.12%)
NVDA   420.21 (-0.48%)
NIO   8.42 (+0.84%)
BABA   85.80 (-1.63%)
AMD   95.67 (-1.76%)
T   15.01 (-0.33%)
F   12.42 (-1.27%)
MU   67.82 (-1.11%)
CGC   0.90 (-4.31%)
GE   109.86 (-1.66%)
DIS   79.85 (-1.43%)
AMC   7.93 (-2.58%)
PFE   32.51 (-1.43%)
PYPL   58.75 (-0.19%)
NFLX   377.97 (-1.77%)
NASDAQ:ALNY

Alnylam Pharmaceuticals (ALNY) Insider Trading & Ownership

$174.86
+4.09 (+2.40%)
(As of 02:52 PM ET)
Compare
Today's Range
$170.05
▼
$175.00
50-Day Range
$170.77
▼
$211.65
52-Week Range
$168.65
▼
$242.97
Volume
378,148 shs
Average Volume
682,589 shs
Market Capitalization
$21.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$247.40
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Alnylam Pharmaceuticals (NASDAQ:ALNY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$10.32 M
Get ALNY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alnylam Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALNY Insider Buying and Selling by Quarter


Alnylam Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345  
8/4/2023Jeffrey V PoultonCFOSell3,460$185.85$643,041.0015,873  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890  
4/27/2023Jeffrey V PoultonCFOSell977$194.59$190,114.4311,706  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00  
3/6/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Buy$199.70$15,001 - $50,000
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345  
2/2/2023Indrani Lall FranchiniEVPSell1,675$226.01$378,566.753,500  
(Data available from 1/1/2013 forward)












ALNY Insider Trading Activity - Frequently Asked Questions

Who is on Alnylam Pharmaceuticals's Insider Roster?

The list of insiders at Alnylam Pharmaceuticals includes Akshay Vaishnaw, Indrani Lall Franchini, Jeffrey V Poulton, John Maraganore, Laurie Keating, Phillip A Sharp, Pushkal Garg, Steven M Paul, Tolga Tanguler, and Yvonne Greenstreet. Learn more on insiders at ALNY.

What percentage of Alnylam Pharmaceuticals stock is owned by insiders?

1.40% of Alnylam Pharmaceuticals stock is owned by insiders. Learn more on ALNY's insider holdings.

Which Alnylam Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ALNY shares in the last 24 months: Akshay Vaishnaw ($1,015,146.75), Indrani Lall Franchini ($1,113,566.75), Jeffrey V Poulton ($833,155.43), John Maraganore ($5,827,906.56), Pushkal Garg ($5,381,563.60), Steven M Paul ($2,560,350.00), Tolga Tanguler ($1,320,287.40), and Yvonne Greenstreet ($2,235,796.30).

How much insider selling is happening at Alnylam Pharmaceuticals?

Insiders have sold a total of 109,896 Alnylam Pharmaceuticals shares in the last 24 months for a total of $20,287,772.79 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:ALNY) was last updated on 9/26/2023 by MarketBeat.com Staff

My Account -